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CD8 T Cells Regulate Allergic Contact Dermatitis by
Modulating CCR2–Dependent TNF/iNOS–Expressing
Ly6CþCD11bþ Monocytic Cells
Shu Zhen Chong1,2,3, Kar Wai Tan3, Fiona H.S. Wong1, Yen Leong Chua1, Yafang Tang1,2, Lai Guan Ng3,
Veronique Angeli1,4 and David M. Kemeny1,2,4
Monocytes and their derived cells have critical roles in inflammation and immune defense. However, their
function in skin diseases such as allergic contact dermatitis remains poorly defined. Using a model of contact
hypersensitivity (CHS) toward 2,4-dinitrochlorobenzene, we show that Ly6CþCD11bþ monocytic cells participate
in the pathophysiology of CHS and their accumulation is regulated by effector CD8 T cells. These Ly6CþCD11bþ
monocytic cells are the primary contributors of tumor necrosis factor-a (TNF-a) and inducible nitric oxide
synthase (iNOS) and derive from Ly6ChiCCR2þ monocytes, as they were absent in non-inflamed skin and
accumulate as a consequence of inflammation in a C–C chemokine receptor type 2 (CCR2)–dependent manner.
Importantly, CCR2 / mice, or wild-type mice depleted of monocytes via clodronate liposomes, display a
marked decrease in TNF-a and iNOS expression accompanied by attenuated skin inflammation. Using transgenic
mice and antibody depletion, we show that effector CD8 T cells regulate the accumulation of Ly6CþCD11bþ
monocytic cells through IL-17 and activate them for TNF-a and iNOS through IFN-g. CD8 T cell–derived IFN-g was
also critical for the accumulation of the major histocompatibility complex II–expressing Ly6CþCD11bþ subset,
which expressed intermediate levels of CD11c and costimulatory molecules. Taken together, our findings provide
further insight into the pathophysiology of allergic contact dermatitis by showing that CD8 T cells regulate the
inflammatory cascade through TNF/iNOS–expressing Ly6CþCD11bþ monocytic cells.
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INTRODUCTION
Allergic contact dermatitis represents a major component of
occupational skin diseases that is caused by a delayed-type
hypersensitivity response toward low-molecular-weight com-
pounds. Its immunological mechanisms are studied using
murine models of contact hypersensitivity (CHS) that are
induced by topical exposure to haptens in sensitized mice
(Grabbe and Schwarz, 1998). Clinical symptoms of the
disease include erythema, edema, and vesiculation that are
usually treated by glucocorticoids (Belsito, 2000), which
results in decreased inflammatory mediators such as tumor
necrosis factor-a (TNF-a) and nitric oxide (NO) (Barnes, 1998).
NO is synthesized through nitric oxide synthase (iNOS) and
results in vasodilation and tissue damage (Aktan, 2004),
whereas TNF-a regulates leukocyte migration, activation,
and vascular permeability (Tracey and Cerami, 2013). The
absence of either factor results in reduced CHS responses
(Piguet et al., 1991; Ross et al., 1998; Nakae, 2003). TNF-a
and iNOS are expressed in non-immune cells such as
endothelial cells, fibroblasts, and keratinocytes (Scho¨n et al.,
2001; Bashir et al., 2008). Their primary production in skin
diseases has also been attributed to activated macrophages
(Wang et al., 2006; Tuckermann et al., 2007). Tissue
macrophages are heterogeneous, consisting of a self-
renewing population derived from progenitors before birth
and a population derived from monocytes during
inflammation (Schulz et al., 2012; Hashimoto et al., 2013;
Yona et al., 2013). In particular, inflammatory monocytes are
Ly6ChiCCR2þ and their derived cells include macrophages
and dendritic cells (DCs) that may share similar phenotypic
characteristics (Auffray et al., 2009). The characterization
of these cells during the elicitation of CHS thus remains
unclear.
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CD8 T cells are the dominant mediators of CHS in mouse
models utilizing both strong and weak sensitizers (Vocanson
et al., 2006). Effector CD8 T cells initiate CHS upon infiltration
into the challenge site, which results in keratinocyte apoptosis
through their cytotoxicity (Akiba et al., 2002). CD8 T cells also
develop into distinct subpopulations expressing IL-17 and
IFN-g that mediate the recruitment of neutrophils and
activation of reactive oxidative species (He et al., 2009; Kish
et al., 2011). In this study, we observed the accumulation of
C–C chemokine receptor type 2 (CCR2)–dependent TNF/
iNOS–expressing Ly6CþCD11bþ monocytic cells that was
regulated by CD8 T cell–derived IL-17 and IFN-g. Our
study hence provides further insight into the regulatory role
of CD8 T cells on monocytic cells in the pathophysiology
of CHS.
RESULTS
CHS elicitation with DNCB is accompanied by infiltration
of neutrophils, monocytic cells, and expression of TNF-a
and iNOS
We first determined the expression of inflammatory mediators
between two allergens that cause occupational skin diseases,
namely 2,4-dinitrochlorobenze (DNCB) and trimellitic an-
hydride (TMA) (Dearman et al., 1992), of which the latter is
a non-classical contact allergen and possess a weaker sensiti-
zing potential (van Och et al., 2000). The concentrations
of these allergens were selected based on their ability to
induce comparable levels of immunogenicity with respect to
lymphocyte proliferative responses induced in the local lymph
node assay (Dearman et al., 1997; Vandebriel et al., 2000). In
contrast to TMA, DNCB–treated mice resulted in classical
pathophysiological characteristics of CHS, shown by a sub-
stantial increase in ear thickness (Figure 1a), accompanied by
edema and extensive cell infiltration (Figure 1b). Although
there was no significant expression of TNF-a and iNOS in the
epidermis (data not shown), intracellular staining of TNF-a
and iNOS expression in dermal cells revealed an increase
in these mediators expressed by CD45þCD11bþ cells in
DNCB–treated mice (Figure 1c) that peaked 24 hours after
challenge (Figure 1d and 1e). Among these CD45þCD11bþ
cells, we found not only a significant increase in neutrophils
(Ly6GþLy6CþCD11bþ ) (Figure 1f) but also a 6-fold increase
in monocytic cells (Ly6GLy6CþCD11bþ ) in DNCB–treated
compared with TMA–treated mice (Figure 1g). Both neutro-
phils and monocytic cells were absent in vehicle-treated mice
(Figure 1f and g). These data hence indicate that substantial
inflammation, accompanied by the infiltration of neutrophils,
monocytic cells, and TNF-a/iNOS expression, was only
observed in the classical model of CHS with DNCB, as these
observations were significantly attenuated in mice sensitized
with TMA.
TNF-a and iNOS are primarily expressed by two populations
of Ly6CþCD11bþ monocytic cells irrespective of their MHCII
expression in the inflamed skin
To further characterize the primary cell sources of TNF-a
and iNOS in the inflamed skin of DNCB–elicited CHS, we first
determined the proportion of these mediators that were
expressed by neutrophils as their expression has been repo-
rted by others (Feiken et al., 1995; Tsukahara et al., 2001).
Intracellular cytokine staining revealed that neutrophils
(CD45þCD11bþLy6Gþ ) expressed relatively low levels of
these mediators compared with CD45þCD11bþLy6G cells
during CHS (Figure 2a). The depletion of neutrophils with anti-
Ly6G antibodies during CHS also resulted in a significant
decrease but incomplete abrogation of the inflammatory
response (Figure 2b). These results suggest that other cells
may contribute to the residual inflammation and TNF-a/iNOS
expression. We next examined the expression of Ly6C
and major histocompatibility complex II (MHCII) on CD45þ
Ly6G cells (Figure 2c), as MHCII identifies monocytes,
macrophages, and DCs (Ingersoll et al., 2010), whereas
Ly6C has been used to distinguish monocytes from resident
macrophages and DCs (Nahrendorf et al., 2007; Auffray
et al., 2009). We found that Ly6CþCD11bþ cells were the
primary sources of TNF-a and iNOS regardless of MHCII
expression (R2 and R3 gates)(Figure 2c) and this was consis-
tent for both percentages and median florescence index
(Figure 2d). Ly6CþCD11bþ cells (R2 and R3 gates) also
produced NO (Figure 2e) and these cells secreted higher levels
of NO compared with the non-Ly6C-expressing dermal cells
(R1 and R4 gates) (Figure 2f). Notably, these results are
consistent with their expression of iNOS (Figure 2c and d).
Ly6CþCD11bþ cells (R2 and R3 gates) were negative for
B220 and NK1.1 (data not shown), further confirming that they
were neither B cells nor NK cells. Ly6CþCD11bþMHCIIþ
cells (R2 gate) also expressed intermediate levels of CD11c
and F4/80, as well as costimulatory molecules CD80
and CD86 (Figure 2g). Taken together, these data suggest
that Ly6C is a crucial determining marker for TNF-a/iNOS
expression among CD11bþLy6G monocytic cells in the
inflamed skin.
Impaired CCR2 signaling abrogates the accumulation of
Ly6CþCD11bþ monocytic cells and TNF-a and iNOS
expression during CHS
Ly6Chi monocytes use CCR2 to egress from the bone marrow
into the circulation (Serbina and Pamer, 2006). It is well
established that mice deficient in CCR2 signaling display
drastic decreases in Ly6Chi blood monocytes and monocyte-
derived cells (Shi and Pamer, 2011). In contrast, conventional
DCs and resident macrophages that are not derived from
Ly6Chi blood monocytes are unaffected by CCR2 deficiency
(Lumeng et al., 2007; Langlet et al., 2012). Therefore,
we utilized such differential CCR2 requirements to confirm
the origin of these TNF/iNOS–expressing Ly6CþCD11bþ
cells. As expected, both Ly6CþCD11bþMHCII and Ly6Cþ
CD11bþMHCIIþ cells were significantly abrogated in
CCR2 / compared with wild-type (WT) mice (Figure 3a).
In addition, the absence of CCR2 signaling resulted in
a marked decrease in TNF-a– and iNOS–expressing cells
(Figure 3b), accompanied by reduced ear thickness (Figure 3c)
and inflammation (Figure 3d). CCR2 / mice were pre-
viously shown to display reduced DC migration (Sato et al.,
2000; Jimenez et al., 2010), which could lead to reduced
T cell responses during the sensitization phase, and hence,
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attenuated skin inflammation. To rule out this confounding
factor, we performed adoptive transfer experiments of
WT DNCB–primed CD8 T cells into WT or CCR2 /
recipient mice. Nevertheless, CCR2 / recipient mice dis-
played reduced CHS responses compared with WT recipients
(Figure 3e), suggesting that the attenuated inflammation was
due to the lack of Ly6CþCD11bþ monocytic cell recruitment
rather than a defect in T cell responses. Hence, these results
demonstrate that TNF/iNOS–expressing Ly6CþCD11bþ cells
accumulate in a CCR2–dependent manner and contribute to
CHS pathology.
Depletion of monocytes via clodronate liposomes abrogated
TNF/iNOS–expressing Ly6CþCD11bþ cells and attenuated skin
inflammation
To further confirm the monocytic origin and pathologic
contribution of TNF/iNOS–expressing Ly6CþCD11bþ cells,
we depleted monocytic cells via administration of clodronate-
containing liposomes as described by others (Sunderko¨tter
et al., 2004). Notably, this protocol allows the depletion
of circulating monocytes without affecting the activity of
neutrophils (Qian et al., 1994; van Rooijen and Sanders,
1994). Intravenous administration of clodronate, but not
0.6
0.4
0.2
0
0 24 48 72
Hours after challenge
Ea
r t
hi
ck
ne
ss
 (m
m)
***
+++ ***
+++
***
+++
** **
*
DNCB
TMA
Vehicle
Veh
DNCB
TMA
Vehicle TMA DNCB Vehicle TMA DNCB
iN
O
S 0.3% 1% 7% 1% 3% 7%
TN
F-
α
CD11b CDD11b
15
10
5
0
0 24 48 72
Hours after challenge
+++
***
DNCB
TMA
Vehicle
++
**
***
iN
O
S 
(ce
lls
 × 
10
4 )
25
20
15
10
5
0
TN
F-
α
 
(ce
lls
 × 
10
4 )
DNCB
TMA
Vehicle
DNCB
TMA
Vehicle
DNCB
TMA
Vehicle
+++
***
+++
*** +++
******
0 24 48 72
Hours after challenge
+++
***
+++
***
+++
***
+++
***
+++
***
+++
***
* *
50
40
30
20
10
0
0 24 48 72
Hours after challenge
N
eu
tro
ph
ils
 (c
ell
s ×
 
10
4 ) 80
60
40
20
0
0 24 48 72
Hours after challenge
* ** **M
on
oc
yt
ic 
ce
lls
(ce
lls
 × 
10
4 )
Figure 1. 2,4-Dinitrochlorobenzene (DNCB)–elicited contact hypersensitivity (CHS) results in tumor necrosis factor-a/inducible nitric oxide synthase
(TNF-a/iNOS) expression with neutrophil and monocytic cell infiltration. (a) Ear thickness of mice treated with DNCB (red circle), trimellitic anhydride
(TMA) (blue square), and vehicle (black triangle). (b) Hematoxylin and eosin (H&E) staining of ear tissue sections. Bar¼ 200mm. (c) Dermal CD45þ
TNF-a– and iNOS–expressing CD11bþ cells. Dermal CD45þCD11bþ cell numbers positive for (d) iNOS and (e) TNF-a. Cell numbers of (f) neutrophils
(CD45þCD11bþLy6GþLy6Cþ ) and (g) monocytic cells (CD45þCD11bþLy6GLy6Cþ ) quantified by flow cytometry. Results shown are mean±SD
of six to eight mice per group and representative of one out of three independent experiments. *Po0.05, **Po0.01, ***Po0.001 (compared with vehicle-treated
mice), þ þPo0.01, þ þ þPo0.001 (compared with TMA–treated mice).
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Figure 2. Characterization of tumor necrosis factor-a/inducible nitric oxide synthase (TNF-a/iNOS)–expressing cells in 2,4-dinitrochlorobenzene
(DNCB)–treated mice. (a) TNF-a/iNOS expression of Ly6Gþ cells gated from CD45þCD11bþ cells. (b) Ear thickness of mice depleted for neutrophils (anti-Ly6G)
compared with control (IgG). ***Po0.001. (c) Percentage of CD11bþTNF-a/iNOSþ cells in each gate (R1¼ Ly6CMHCIIþ ; R2¼ Ly6CþMHCIIþ ;
R3¼ Ly6CþMHCII ; R4¼ Ly6CMHCII ) among CD45þLy6G cells. (d) Percentage and median florescence index (MFI) of TNF-a/iNOS–expressing cells
from each gate. (e) Comparative histograms and (f) MFI expression from each gate of DAF-FM-DA–expressing cells (measure of NO). *Po0.05, **Po0.01;
***Po0.001 (compared with R1 gate). (g) MFI of indicated markers on cells from each gate. Results shown are mean±SD of five to seven mice per group and
representative of one out of three independent experiments. Inc., increase; MHCII, major histocompatibility complex II.
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phosphate-buffered saline (PBS), liposomes resulted in the
depletion of all blood monocytes and a subsequent absence
of Ly6CþCD11bþ cells in the challenged skins of DNCB–
treated mice (Figure 4a). Importantly, clodronate adminis-
tration did not affect the resident dermal Ly6C cells
(Figure 4b). In addition, the absence of Ly6CþCD11bþ cells
after clodronate administration resulted in a corresponding
decrease in TNF-a and iNOS (Figure 4c) and reduced
ear thickness (Figure 4d). These findings corroborate the mono-
cytic origin of TNF/iNOS–expressing Ly6CþCD11bþ cells and
their contribution towards skin inflammation during CHS.
CD8 T cells mediate the infiltration of Ly6CþCD11bþ
monocytic cells through IL-17 with the accumulation of
Ly6CþCD11bþMHCIIþ cells and activation of TNF-a and
iNOS levels through IFN-c
We next determined which cells regulated the development of
these TNF/iNOS–expressing Ly6CþCD11bþ monocytic cells.
IFN-g was previously shown to regulate the differentiation
of monocytes in the inflamed liver (Bosschaerts et al., 2010).
As CHS elicitation with a weaker sensitizer such as TMA
resulted in lesser TNF/iNOS–expressing dendritic cells
(Tip-DCs) than DNCB, we determined if this discrepancy
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Figure 3. Impaired C–C chemokine receptor type 2 (CCR2) signaling abrogates Ly6CþCD11bþ monocytic cells and tumor necrosis factor-a/inducible
nitric oxide synthase (TNF-a/iNOS) expression during contact hypersensitivity (CHS). (a) MHCIIþ /–expressing Ly6CþCD11bþ dermal cells gated from
CD45þLy6G cells were quantified by flow cytometry. (b) CD45þCD11bþ cells were gated and TNF-a– and iNOS–expressing cells quantified by flow
cytometry. (c) Increase in ear thickness. (d) Hematoxylin and eosin (H&E) staining of ear tissue sections. Bar¼200mm. (e) CHS response, measured by increase
in ear thickness, after adoptive transfer of 2,4-dinitrochlorobenzene (DNCB)–primed wild-type (WT) CD8 T cells into naive WT (red circle) or CCR2 /
(blue square) recipients. Results shown are mean±SD of six mice per group and representative of one out of four independent experiments. *Po0.05, **Po0.01,
and ***Po0.001. Inc., increase; MHCII, major histocompatibility complex II.
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was associated with reduced IFN-g. Indeed, we found that
TMA–elicited CHS resulted in reduced IFN-g levels compared
with the classical CHS elicitation with DNCB (Supplementary
Figure S1a online). At the same time, we also found reduced
IL-17 and CD8 expression levels in the skin (Supplementary
Figure S1a online). These results led us to determine whether
CD8 T cell recruitment was reduced in TMA–elicited CHS. As
dermal CD8 T cells displayed a downregulation of CD3 and
TCRab receptor 24 hours after challenge, we adoptively trans-
ferred presensitized carboxyfluorescein succinimidyl ester–
labeled CD8 T cells into WT recipient mice. We found that
TMA–treated mice had a significant decrease in both percen-
tage (Supplementary Figure S1b online) and carboxyfluores-
cein succinimidyl ester–labeled cell numbers (Supplementary
Figure S1c online) compared with DNCB–treated mice.
Hence, these results prompted us to determine if CD8 T cells
regulated TNF/iNOS–expressing Ly6CþCD11bþ monocytic
cells in the classical model of DNCB–elicited CHS.
To understand how CD8 T cells regulate Ly6CþCD11bþ
monocytic cells, we performed CHS with DNCB on b2
microglobulin (b2m)
 / mice (which were deficient in CD8
T cells due to defective MHCI priming; Koller et al., 2010)
and mice depleted with anti-CD8 antibodies (CD8dep mice).
Both Ly6CþCD11bþMHCII and Ly6CþCD11bþMHCIIþ
cell numbers were significantly reduced in the dermis of
b2m
 / and CD8dep compared with WT mice (Figure 5a).
We next determined the CD8 T cell factors that regulated
monocytic cells by performing CHS on IFN-g / , perforin /
mice, and mice neutralized with anti-IL-17 antibodies
(IL-17neu mice). Among these mice, only IL-17neu mice
displayed a significant decrease in Ly6CþCD11bþMHCII
cell numbers (Figure 5b). Although both IFN-g / and
IL-17neu mice displayed significant decreases in Ly6Cþ
CD11bþMHCIIþ cell numbers, the decrease in IFN-g /
mice was significantly more pronounced than that displayed
in IL-17neu mice (Figure 5b). We next determined if CD8
T cells and their factors affected TNF/iNOS expression levels.
b2m
 / and CD8dep mice displayed a significant decrease in
iNOS– and TNF-a–expressing cells (Figure 5c), although this
decrease was more pronounced for iNOS compared with
TNF-a. Among the CD8 T cell factors, only IFN-g / mice
displayed a significant decrease in iNOS and TNF-a expres-
sion (Figure 5d). Finally, we verified if the adoptive transfer of
DNCB–primed CD8 T cells could induce CHS and monocytic
cells through IFN-g and IL-17. Adoptive transfer of DNCB–
primed CD8 T cells into naive recipients treated with anti-
IL-17 antibodies (IL-17neu mice), as well as transfer of CD8
T cells from IFN-g / mice into naive recipients, resulted in
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decreased CHS responses compared with naive recipients
that received only WT cells (Figure 5e). Notably, CD8 T cells
in IL-17neu mice resulted in decreased Ly6C
þCD11bþ
MHCII cells, whereas IFN-g / CD8 T cells resulted in
the least numbers of Ly6CþCD11bþMHCIIþ cells (Figure 5f).
Taken together, these results demonstrate that CD8 T cells
mediate the infiltration of Ly6CþCD11bþ monocytic cells
through IL-17 with the accumulation of Ly6CþCD11bþ
MHCIIþ cells and activation of TNF-a and iNOS levels
through IFN-g.
DISCUSSION
In this study, we show that non-granulocytic Ly6CþCD11bþ
myeloid cells are the primary contributors of TNF-a and iNOS
during CHS elicitation in the skin. These dermal Ly6Cþ
CD11bþ cells are derived from Ly6ChiCCR2þ monocytes as
they accumulate as a consequence of inflammation in a
CCR2-dependent manner and are abrogated when circulating
monocytes were depleted. These TNF/iNOS–expressing
Ly6CþCD11bþ monocytic cells consists of a subset that
expresses MHCII (Ly6CþCD11bþMHCIIþ cells) and
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Figure 5. CD8 T cells regulate tumor necrosis factor-a/inducible nitric oxide synthase (TNF/iNOS)–expressing Ly6CþCD11bþ monocytic cells through
IL-17 and IFN-c. Wild-type (WT), b2m
 / , perforin / , IFN-g / , and mice treated with anti-CD8 (CD8dep) or anti-IL-17 (IL-17neu) antibodies were
2,4-dinitrochlorobenzene (DNCB) treated. (a, b) MHCIIþ / expressing Ly6CþCD11bþ cells and (c, d) TNF-a/iNOSþ CD45þCD11bþ cells quantified
by flow cytometry. *Po0.05, **Po01, and ***Po0.001. (e) Increase in ear thickness and (f) Ly6CþCD11bþ cell numbers in naive recipients or recipients
treated with anti-IL-17 antibodies (IL-17neu) after adoptive transfer of WT or IFN-g
 / DNCB–primed CD8 T cells. ***Po0.001 (compared with IL-17neu CD8
transfer), þPo0.05, þ þPo0.01 (compared with IFN-g / CD8 transfer). Results shown are mean±SD of five to eight mice per group and
representative of one out of three independent experiments. b2m, b2 Microglobulin; Inc., increase; MHCII, major histocompatibility complex II.
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intermediate levels of CD11c, CD80, and CD86, representing
Tip-DCs described in other models (Serbina et al., 2003;
Lowes et al., 2005; Bosschaerts et al., 2010). Finally, we show
that CD8 T cells regulated TNF/iNOS–expressing Ly6Cþ
CD11bþ monocytic cells through their expression of IL-17
and IFN-g.
The role of monocytes in the elicitation of CHS has been
poorly described thus far. Here, we show that Ly6CþCD11bþ
monocytic cells are the primary contributors of TNF-a and
iNOS, which are two key mediators in the pathophysiology of
CHS (Piguet et al., 1991; Ross et al., 1998; Nakae, 2003). The
accumulation of Ly6CþCD11bþ monocytic cells occurred
only in substantial numbers in the classical model of DNCB–
elicited CHS and was significantly attenuated with a non-
classical moderate sensitizer like TMA. However, repeated
sensitization with TMA was shown to increase inflammation,
which is associated with increased TNF-a (Schneider et al.,
2008). Future studies are thus needed to address the
contribution of Ly6CþCD11bþ monocytic cells and TNF-a
in the setting of chronic TMA exposure. Although neutrophils
have also been shown to express TNF-a and iNOS (Feiken
et al., 1995; Tsukahara et al., 2001), we found that they
expressed relatively low levels of these mediators in compa-
rison with Ly6CþCD11bþ monocytic cells in the context of
CHS. As neutrophils are also important in the mediation of
CHS (Dilulio et al., 1999; Tuckermann et al., 2007), it is likely
that monocytes and neutrophils contribute to the pathology
through different means. Indeed, neutrophils were shown to
control CHS responses through their expression of Fas ligand,
perforin, and myeloperoxidase instead (He et al., 2009; Kish
et al., 2012). Moreover, we show that while the absence of
either neutrophils or monocytes alone resulted in attenuated
skin inflammation, they did not result in the complete
abrogation of CHS in either model. This observation suggests
that more than one immune cell type is involved in the
pathology of CHS. Consistent with this notion, previous
studies have demonstrated the importance of mast cells in
the contribution to CHS through histamine (Dudeck et al.,
2011) and TNF-a (Biedermann et al., 2000). The primary
expression of TNF-a and iNOS have also been commonly
attributed to activated macrophages in the skin (Wang et al.,
2006; Tuckermann et al., 2007). Macrophages are hetero-
geneous and consist of two distinct populations: (1) resident
macrophages derived from progenitors before birth that are
present in the steady state or (2) inflammatory macrophages
derived from monocytes that are absent in the steady state
(Schulz et al., 2012; Hashimoto et al., 2013; Yona et al.,
2013). Moreover, classically activated M1 macrophages share
many similar phenotypic characteristics with CCR2–depen-
dent monocyte-derived DCs (Tip-DCs), such as CD11b, F4/80,
and intermediate levels of CD11c (Geissmann et al., 2010).
We show that TNF/iNOS–expressing Ly6CþCD11bþ cells are
absent in the non-inflamed skin and their accumulation during
CHS depends on CCR2 signaling. These results, as well as
monocyte depletion using clodronate liposomes that does
not affect other dermal resident populations, suggest that
TNF/iNOS–expressing Ly6CþCD11bþ cells are monocytic
in origin and appear as a consequence of inflammation, rather
than resident skin macrophages that are activated by inflam-
matory stimuli. These findings thus advance our characteriza-
tion of TNF/iNOS inflammatory cells in the context of allergic
contact dermatitis that may be beneficial for future therapeutic
targeting.
CD8 T cells initiate CHS principally through their cytotoxi-
city and production of the cytokines IFN-g and IL-17 (Akiba
et al., 2002; He et al., 2009). In our study, we provide further
insight by showing that CD8 T cells regulate CHS responses by
facilitating the accumulation of TNF/iNOS–expressing Ly6Cþ
CD11bþ monocytic cells. In particular, we show that IL-17
mediates Ly6CþCD11bþ monocytic cell infiltration, while
IFN-g regulates the accumulation of Ly6CþCD11bþMHCIIþ
cells (Tip-DCs) and TNF/iNOS expression. Although
a previous CHS study by He et al. (2009) has shown that
IL-17 regulates the infiltration of CD11bþ macrophages, the
origin of these macrophages remains unclear. In our IL-17
neutralization studies, we found a decrease in non-granulo-
cytic CD11bþ cells that was attributed to a decrease in the
Ly6Cþ monocytic population, suggesting that the decrease in
CD11bþ macrophages in the study by He et al. may have
resulted from decreased infiltration of Ly6CþCD11bþ mono-
cytic cells. In support of this finding, IL-17 has also been
shown to regulate monocyte infiltration in a model of rheuma-
toid arthritis (Shahrara et al., 2009). Although the role of IFN-g
has been previously reported to regulate Tip-DCs in the
inflamed liver (Bosschaerts et al., 2010), we are the first to
show that CD8 T cells are the main cells regulating
Ly6CþCD11bþMHCIIþ cells (Tip-DCs) and TNF-a and
iNOS expression. Intriguingly, IFN-g expression by CD8
T cells was found to be transient and peaked 24 hours after
challenge (Akiba et al., 2002), which coincided with our data
showing a transient expression of both TNF-a and iNOS that
peaked at a similar timepoint. Although it is unclear whether
IFN-g activates Ly6CþCD11bþ monocytic cells for MHCII
expression, such that Tip-DCs arise directly from the
differentiation of Ly6CþCD11bþMHCII cells, others have
shown that IFN-g differentiated Tip-DCs in the inflamed liver
from Ly6CþCD11bþMHCII monocytic cells (Bosschaerts
et al., 2010). The differentiation of Tip-DCs from Ly6Cþ
CD11bþMHCII cells is also supported by our previous
in vitro study, which demonstrated the acquisition of Tip-DC
characteristics such as MHCII by human monocytes after
exposure to IFN-g (Chong et al., 2011).
The ability of CD8 T cells to regulate TNF/iNOS–expressing
Ly6CþCD11bþ monocytic cells has important immune
implications. Notably, the classical model of CHS with
allergens such as DNCB is typically associated with a T helper
cell type 1/type 1 cytotoxic cell–mediated immune response
(Grabbe and Schwarz, 1998). Although it is unclear if Tip-DCs
may further exacerbate CHS pathology by sustaining T helper
cell type 1 responses, we and others have shown that Tip-DCs
represent a major class of T helper cell type 1–regulated
effector cells (Traynor et al., 2002; De Trez et al., 2009; Chong
et al., 2011) and support T helper cell type 1 responses
through their secretion of TNF-a and NO (Brown et al., 2003;
Chong et al., 2011; Lee et al., 2011). The contribution of TNF/
iNOS–expressing Ly6CþCD11bþ monocytic cells to CHS
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pathology in a CCR2–dependent manner may also explain the
attenuated outcome of CHS when CCL2 was inhibited through
systemic delivery of small interfering RNA (Ishimoto et al.,
2008). Finally, our data demonstrating the regulatory role
of CD8 T cells on monocytic cells are similarly substantiated
in obesity and human psoriasis studies, whereby CD8 T cells
exacerbated adipose tissue inflammation through F4/80þ
CD11bþ cells (Nishimura et al., 2009), while Tip-DCs and
inflammation were reduced after T cells were abrogated
through alefacept treatment (Chamian et al., 2005) in the latter.
Taken together, our results highlight a previously unde-
scribed role for CD8 T cells in the elicitation of CHS. In
addition to their reported roles in keratinocyte apoptosis
(Akiba et al., 2002) and activation of endothelial cells for
neutrophil recruitment (Kish et al., 2011), we now show
that CD8 T cells further regulate allergic contact dermatitis
through the mediation of TNF/iNOS–expressing Ly6Cþ
CD11bþ monocytic cells. Finally, the identification of Ly6Cþ
CD11bþ monocytic cells as critical contributors of TNF-a and
iNOS and their dependence on CCR2 signaling provides
further insight for targeting of future effective therapies.
MATERIALS AND METHODS
Animals
Age- and sex-matched C57BL/6 mice (8–10 weeks) were purchased
from the animal breeding center of National University of Singapore
(Singapore). IFN-g / , b2m / , CCR2 / , and perforin / mice,
on C57BL/6 background, were purchased from the Jackson Labora-
tory (Bar Harbor, ME). All mice were maintained under pathogen-free
conditions in satellite animal housing unit of the Center for
Comparative Medicine (Singapore, Singapore). All experiments were
conducted in accordance with institutional guidelines and were
approved by NUS institutional animal care and use committee
(IACUC) under the protocol number 029/09.
CHS responses
Mice were shaved on the flanks 1 day before sensitization with 50ml
of either 1% DNCB (97% pure; Sigma Aldrich, Singapore, Singapore)
or 10% TMA (99% pure; Sigma Aldrich) diluted w/v in vehicle (4:1
acetone:olive oil) and challenged on day 5 with 25ml of allergen on
both dorsal and ventral sides of the ears. CHS responses were
assessed by an increase in ear thickness using a micrometer
(Mitutoyo, Kanagawa, Japan) at specific time points or killed for
sample collection 24 hours after challenge. Increase in ear thickness
was calculated as T T0, where T and T0 represent values of ear
thickness after and before challenge, respectively.
In some experiments, CD8 T cells were depleted in vivo by
intraperitoneal injection of 53-6.7 antibodies (250mg per mouse;
eBioscience, Singapore, Singapore) on day 3 after sensitization.
Neutrophils were depleted on days 1, 3, and 5 after sensitization
with NIMP-R14 antibodies (250mg per mouse; hybridoma cells were
a kind gift from Dr Jean-Pierre Abastado (Singapore Immunology
Network, Singapore)). IL-17 was depleted on days 4 and 5 after
sensitization with anti-IL-17 antibodies (200mg per mouse; clone
50104; R&D Systems, Singapore, Singapore). Depletion was carried
out with matching mice using respective rat IgG antibodies as a
control (eBiosicence). In all cases, specific depletion exceeded 97%
on the day of sample collection. To deplete blood monocytes, 200ml
of liposomes containing clodronate or PBS (purchased from N van
Rooijen (Amsterdam, The Netherlands)) were injected intravenously
into mice 6 hours before challenge on day 5.
To examine adoptive transfer of CHS responses, WT or
IFN-g /mice were sensitized on two consecutive days with allergen
and draining lymph nodes excised 5 days later as described (Xu et al.,
1996). CD8 T cells were purified from draining lymph nodes using
MACS system according to the manufacturer’s instructions (Miltenyi
Biotec, Singapore) with a purity of 497% and 5 106 CD8 T cells
were transferred intravenously into naive WT or CCR2 / mice.
Recipient mice were challenged immediately with allergen and
samples harvested 24 hours later. To examine the effect of IL-17
from CD8 T cells in adoptive transfer CHS responses, naive WT
recipient mice were treated with 200mg per mouse of anti-IL-17
antibodies 1 day before and on the day of cell transfer.
Tissue processing
Mouse ears were split into dorsal and ventral parts and incubated for
60 min at 37 1C/5% CO2 in 2.4 mg ml
 1 of Dispase (Gibco, Invitro-
gen, Singapore, Singapore) diluted in RPMI-1600 (Gibco). The
epidermal and dermal sheet were minced and incubated separately
for 2.5 h at 37 1C/5% CO2 in Hank’s buffer salt solution containing
1 mg ml 1 collagenase type IV (Gibco) as described (Ginhoux et al.,
2007) but with the concurrent inclusion of 1ml ml 1 of Golgistop (BD
Pharmingen, Singapore, Singapore). Cells were passed through a 19 G
syringe to obtain a homogeneous cell suspension.
Antibodies and flow cytometry
Dissociated single cells were excluded for dead cells using the LIVE/
DEAD fixable aqua dead cell stain kit (Invitrogen, Singapore,
Singapore) according to the manufacturer’s instructions followed by
staining with the following antibodies: CD45-APC-Cy7 (30-F11; BD
Pharmingen, Singapore, Singapore), CD45-PB (30-F11; BioLegend,
Singapore), CD11b-PE-Cy7 (M1/70; eBioscience), CD11b-PCP-Cy5.5
(M1/70; eBioscience), I-A/I-E-PCP-Cy5.5 (M5/114.15.2; eBioscience),
Ly6G-APC (1A8; BioLegend), B220-PCP-Cy5.5 (RA3-6B2; BioLe-
gend), NK1.1-FITC (PK136; eBioscience), CD11c-PE-Cy7 (N418;
BioLegend), CD80-AF488 (16-10A1; BioLegend), CD86-PE-Cy7
(GL-1; BioLegend), F4/80-FITC (Cl:A3-1; AbD Serotec), Ly6C-PB
(HK1.4; BioLegend), and Ly6C-APC-Cy7 (HK1.4; BioLegend). Cells
were then fixed, permeabilized (Fix/Perm Kit; eBioscience), and
analyzed for intracellular TNF-a and iNOS with AF488-conjugated
TNF-a (BioLegend, Genomax Technologies, Singapore) and uncon-
jugated rabbit anti-mouse iNOS (BD Biosciences, Singapore)
followed by APC- or PB-conjugated anti-rabbit IgG (Invitrogen). To
detect intracellular NO, 5mm of DAF-FM diacetate (Invitrogen) in PBS
was added to cells for 30 min at 4 1C. Cells were washed and
replaced with fresh PBS for an additional 15 minutes before flow
cytometry analysis. DAF-FM fluorescence emission is a direct measure
of intracellular NO content. Cell counts were determined using
Count Bright Absolute Counting Beads (Molecular Probes, Invitrogen,
Singapore). Acquisition was performed using CyAn ADP (Beckman
Coulter, Singapore) and data were analyzed using the FlowJo software
(version 9.3.2; Tree Star, Ashland, OR).
Statistical analysis
Data are expressed as means±SD. The statistical analysis of the
results was performed by unpaired t-test or means of analysis of
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variance with Tukey’s post test as appropriate using the Graph Pad
Prism 6 Software. P-values o0.05 were considered significant.
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